Page last updated: 2024-12-08

3,6-bis(2-(diethylamino)ethoxy)acridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

3,6-bis(2-(diethylamino)ethoxy)acridine: structure given in first source; an analog of tilorone in which the fluorenone residue has been replaced by acridine; induces lysosomal storage of sufated glycosaminoglycans [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID162541
CHEMBL ID1191507
SCHEMBL ID9827224
MeSH IDM0202716

Synonyms (8)

Synonym
CHEMBL1191507
3,6-bis(2-(diethylamino)ethoxy)acridine
79940-05-9
SCHEMBL9827224
3,6-bis(2-diethylaminoethoxy)acridine
BHPCYWKICVHWTQ-UHFFFAOYSA-N
DTXSID10276517
3,6-bis[2-(diethyl-amino)-ethoxy]acridine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]